PAG
MBOT icon

Private Advisor Group’s Microbot Medical MBOT Stock Holding History

Private Advisor Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Buy
22,851
+300
+1% +$612 ﹤0.01% 2474
2026
Q1 		$54.3K Buy
+22,551
New +$50.4K ﹤0.01% 2573

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Private Advisor Group's MBOT Position: Q2 2026 in Review

Private Advisor Group increased its Microbot Medical (MBOT) stake by 1.3% in Q2 2026, buying an estimated $612 and bringing the position to 22,851 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2474.

Private Advisor Group first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $54.3K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Private Advisor Group held 22,851 shares of Microbot Medical worth $44.6K as of Q2 2026.
  • Private Advisor Group bought 300 Microbot Medical shares in Q2 2026, an estimated $612.
  • Microbot Medical made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2474 holding.
  • Private Advisor Group first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Private Advisor Group's Microbot Medical position peaked at $54.3K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.